Franklin HAD-3038 User Manual

HAD-3038
Medical Book Card
The M ed ical Letter
HANDBOOK
ADVERSE
DRUG
INTERACTIONS
User’s Guide
Quick Reference Guide
To Start Using a Book Card
1. Install the book card in a slot in the back of the Medical Book System platform.
2. Turn the platform on.
CARD
3. If needed, press use the
or to highlight its
and then
icon.
ENTER
4. Press
to select it.
T o Find All Other Drug Interactions
1.
2. Highlight a drug by typing its name
3. If needed, select more drugs by
4. Press
5. Highlight an interaction, if any, and
CLEAR
Press
or pressing
ENTER
.
or and then press
to select it.
highlighting them and pressing
ENTER
.
MORE
.
ENTER
press
to view it.
20
T o Find Drug Interactions
1.
2. Highlight a drug by typing its name
3. Select more drugs by highlighting
4. Press
5. Highlight an interaction, if any, and
CLEAR
Press
or pressing
ENTER
.
or and then press
to select it.
them and pressing
SEARCH
.
ENTER
press
to view it.
ENTER
.
T o Find a Glossary Entry
1.
2. Highlight a drug by typing its name
3. Press
4. Use , DN, or
5. Press
CLEAR
Press
or pressing
SPEC
BACK
.
or .
.
SPACE
to scroll.
to go back.
License Agreement
READ THIS LICENSE AGREEMENT BEFORE USING THE MEDICAL BOOK SYSTEM.
YOUR USE OF THE MEDICAL BOOK SYSTEM DEEMS THAT YOU ACCEPT THE TERMS OF THIS LICENSE. IF YOU DO NOT AGREE WITH THESE TERMS, YOU MAY RETURN THIS PACKAGE WITH PURCHASE RECEIPT TO THE DEALER FROM WHICH YOU PURCHASED THE MEDICAL BOOK SYS­TEM AND YOUR PURCHASE PRICE WILL BE REFUNDED. The MEDICAL BOOK SYSTEM means the software product, hardware, and documentation found in this package and FRANKLIN means Franklin Electronic Publishers, Inc.
LIMITED USE LICENSE All rights in the MEDICAL BOOK SYSTEM remain the property of FRANKLIN.
Through your purchase, FRANKLIN grants you a personal and nonexclusive license to use the MEDICAL BOOK SYSTEM. You may not make any copies of the MEDICAL BOOK SYSTEM or of the preprogrammed data stored therein, whether in electronic or print format. Such copying would be in violation of applicable copyright laws. Further, you may not modify, adapt, disassemble, decompile, translate, create derivative works of, or in any way reverse engineer the MEDICAL BOOK SYSTEM. You may not ex­port or re-export, directly or indirectly, the MEDICAL BOOK SYSTEM without com­pliance with appropriate governmental regulations. The MEDICAL BOOK SYSTEM contains Franklin’s confidential and proprietary information which you agree to take adequate steps to protect from unauthorized disclosure or use. This license is effective until terminated. This license terminates immediately without notice from FRANKLIN if you fail to comply with any provision of this license.
1
Contents
Introduction to the HADI.............. 3
Key Guide..................................... 4
Installing Book Cards .................. 5
Selecting a Book .......................... 6
Changing the Settings ................. 6
Viewing a Demonstration ............ 7
Finding Drug Interactions ........... 7
Using the Interactions Menu ..... 10
Using the Glossary .................... 11
Highlighting Search Words ....... 11
Reading Special Markers........... 12
Looking Up Words
in Other Books ........................... 13
Resetting the Medical Book
System........................................ 13
Book Card Care.......................... 14
Specifications and Patents ....... 14
Limited Warranty (U.S. only) ..... 15
Limited Warranty (outside U.S.) 16
FCC Notice ................................. 17
Index ........................................... 18
About Book Card Compatibility
IMPORT ANT This book card can be used only with the Medical Book Sys-
platform and will not function in any
tem other Franklin BOOKMAN
®
platform.
The Medical Book System platform can use Franklin BOOKMAN book cards as well as Medical Book System book cards. However, Franklin BOOK­MAN platforms cannot use Medical Book System book cards.
For More Information
T o learn more about the Medical Book System or other products from Frank­lin Electronic Publishers, call 800-665­5450 or visit the Franklin Web site at www .franklin.com.
2

Introduction to the HADI

This handbook offers a quick guide to possible adverse effects of drug interactions, with brief recommendations for precautionary measures. Pairs of interacting drugs are listed alphabeti­cally, followed by the adverse interaction, its mechanism (in parentheses), references and recommendations for clinical management. These listings are usually based on clinical re­ports. Interactions listed for groups of drugs (such as “cephalosporins” or “antidepressants, tricyclic”) may not have been reported for ev­ery drug in the group; known exceptions to the interaction are noted.
It is not possible to determine the frequency of most interactions. When an interaction is docu­mented by one or two case reports rather than clinical studies or reports in many patients, the year of each report is given as some indication of frequency.
Reports of interactions between more than two drugs have begun to appear in the medical litera­ture. Where these have been documented, they are noted in the comments under interacting pairs of drugs.
CRITERIA FOR LISTING INTERAC­TIONS –– New adverse interactions are continu-
ally being reported; the absence of a listing in this book does not necessarily mean that drugs will not interact when given concurrently. Interactions extrapolated from animal studies or from interac-
tions reported with related drugs, may not be in­cluded here.
Interactions between general anesthetics and drugs likely to be administered during surgery , such as autonomic drugs and local anesthetics, are not included. Interactions useful in therapy, such as the increased plasma concentration of penicil­lin with concurrent use of probenecid, are also not listed. Drug combinations should be looked up under their components.
Common additive effects, such as occur with use of two antihypertensive agents or two central-ner­vous-system depressants or two drugs that affect blood clotting, are generally not listed. Effects ex­pected from the mechanism of a drug’s action, such as that of potassium on digitalis glycosides or calcium on calcium-entry blockers, and useful an­tagonist effects, such as that between a poison and an antidote, are also not included. Most interac­tions of drugs with foods, beverages or other nutri­ents are not listed, but foods interacting with monoamine oxidase inhibitors are included.
MECHANISMS OF INTERACTIONS —
Genetic differences can affect drug metabolism and interactions. Some drugs can interact by changing the metabolism of other drugs, either through inhibition or induction of any of several hepatic enzyme activities or through alterations in hepatic blood flow. Many drugs are metabolized by cytochrome P450 isozymes. A reference table
3
Introduction to the HADI

Key Guide

of drugs and their CYP450 isoforms is available on the internet at www.drug-interactions.com. These isozymes are named according to a stan­dard system, e.g. CYP3A4 or P4503A4. Drugs that are substrates or inhibitors for the same isozyme in vitro are likely to interact, but no inter- action may be detectable, or it may not be clini­cally significant. Other drugs alter the binding of another drug to plasma proteins or tissue recep­tors, alter the distribution of drugs to active recep­tor sites, delay or enhance excretion, or cause additive or synergistic effects.
Elimination of a drug can also be affected by the P-glycoprotein membrane-bound transport sys­tem. Digoxin, for example, moves across cell membranes by a P-glycoprotein controlled pro­cess. Drugs such as quinidine that inhibit P-glyco­protein activity, can increase the serum concentration and toxicity of digoxin.
RECOMMENDATIONS — Monitoring is most important when one of the interacting drugs is stopped or started. Some experienced clinicians may prefer to monitor the patient’s clinical status rather than follow serum concentrations of drugs. Concurrent use of drugs from the same group, e.g., aspirin and other NSAIDs, should be avoided.
Color Keys
MORE
(red) Displays interactions between selected drug(s) and all other drugs in this book.
SPEC
(green) Displays a glossary entry. (yellow) Searches for interactions
SEARCH
among the selected drugs.
LIST
(blue) Lists the items currently se­lected from the main drug list.
Function Keys
BACK
Erases typed letters, or backs up to the previous screen.
CAP
Shifts keys to type capitals or punctuation.
CARD
Exits the currently selected book.
CLEAR
Clears your search and returns to the main drug list.
ENTER
Enters a word, selects a menu item, or starts the highlight in text.
HELP
Displays help messages.
MENU
Displays the main menus.
ON/OFF
Turns the platform on or off.
SPACE
At menus and text, pages down. At entry screens, types a space.
At menus, displays the title of a high-
?
lighted item. At text, displays the current entry title. With
4
() to stand for letters in a word.
CAP
, types an asterisk
Key Guide

Installing Book Cards

Direction Keys
DN
UP
Pages up or down. Moves the cursor, text, or highlight.
Key Combinations*
CARD
+
Transfers a highlighted word between installed book cards.
ENTER
+
At text, highlights special mark­ers (e.g., bibliographic references, MAO inhibitor in­formation , etc.).
+Q-P Types numbers.
DN
+
UP
or
CAP
or
* Hold the first key while pressing the second.
Understanding the Keys
At text, displays the next or previous interaction or search match.
+
Goes to the top or bottom of a menu or text.
The functions of the keys may vary ac­cording to which book card is installed and selected in the platform. To learn how to use a particular book card, read its User’s Guide.
CAUTION Never install or remove a book card when the platform is turned on. If you do, information entered in any installed book cards may be erased.
1. T urn the platform off.
2. T urn the platform over.
3. Align the book card tabs with the notches in a card slot.
4. Press the book card until it snaps into the slot.
Removing Book Cards
CAUTION When you remove a book card from a platform, information en­tered in that book card may be erased.
5
Loading...
+ 15 hidden pages